nodes	percent_of_prediction	percent_of_DWPC	metapath
Isocarboxazid—MAOB—Dopamine metabolism—TYR—skin cancer	0.068	0.585	CbGpPWpGaD
Isocarboxazid—Telangiectasia—Fluorouracil—skin cancer	0.0516	0.0731	CcSEcCtD
Isocarboxazid—MAOA—Dopamine metabolism—TYR—skin cancer	0.0427	0.367	CbGpPWpGaD
Isocarboxazid—Tongue discolouration—Temozolomide—skin cancer	0.0273	0.0387	CcSEcCtD
Isocarboxazid—Lacosamide—SCN10A—skin cancer	0.0263	1	CrCbGaD
Isocarboxazid—MAOB—nerve—skin cancer	0.025	0.166	CbGeAlD
Isocarboxazid—Photosensitivity—Vemurafenib—skin cancer	0.0214	0.0302	CcSEcCtD
Isocarboxazid—MAOA—nerve—skin cancer	0.0214	0.142	CbGeAlD
Isocarboxazid—Memory impairment—Temozolomide—skin cancer	0.0168	0.0238	CcSEcCtD
Isocarboxazid—Lethargy—Imiquimod—skin cancer	0.0163	0.0231	CcSEcCtD
Isocarboxazid—Urinary retention—Imiquimod—skin cancer	0.0152	0.0215	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Vemurafenib—skin cancer	0.0148	0.0209	CcSEcCtD
Isocarboxazid—MAOB—nipple—skin cancer	0.0142	0.0943	CbGeAlD
Isocarboxazid—Neuropathy peripheral—Vemurafenib—skin cancer	0.0142	0.02	CcSEcCtD
Isocarboxazid—Dysuria—Imiquimod—skin cancer	0.0129	0.0183	CcSEcCtD
Isocarboxazid—Constipation—Vismodegib—skin cancer	0.0128	0.0181	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Imiquimod—skin cancer	0.0127	0.018	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Imiquimod—skin cancer	0.0126	0.0179	CcSEcCtD
Isocarboxazid—MAOA—nipple—skin cancer	0.0121	0.0805	CbGeAlD
Isocarboxazid—Neuropathy peripheral—Imiquimod—skin cancer	0.0121	0.0171	CcSEcCtD
Isocarboxazid—MAOA—neck—skin cancer	0.012	0.0796	CbGeAlD
Isocarboxazid—Neuritis—Docetaxel—skin cancer	0.0118	0.0166	CcSEcCtD
Isocarboxazid—Chills—Vemurafenib—skin cancer	0.0116	0.0165	CcSEcCtD
Isocarboxazid—Coma—Fluorouracil—skin cancer	0.0111	0.0157	CcSEcCtD
Isocarboxazid—Lethargy—Dactinomycin—skin cancer	0.0108	0.0153	CcSEcCtD
Isocarboxazid—Euphoric mood—Fluorouracil—skin cancer	0.0105	0.0148	CcSEcCtD
Isocarboxazid—Diarrhoea—Vismodegib—skin cancer	0.0102	0.0144	CcSEcCtD
Isocarboxazid—MAOB—connective tissue—skin cancer	0.0101	0.0669	CbGeAlD
Isocarboxazid—Photosensitivity—Fluorouracil—skin cancer	0.0101	0.0142	CcSEcCtD
Isocarboxazid—Chills—Imiquimod—skin cancer	0.00993	0.014	CcSEcCtD
Isocarboxazid—Ataxia—Temozolomide—skin cancer	0.00901	0.0128	CcSEcCtD
Isocarboxazid—Lethargy—Fluorouracil—skin cancer	0.00901	0.0128	CcSEcCtD
Isocarboxazid—Nausea—Vismodegib—skin cancer	0.00886	0.0125	CcSEcCtD
Isocarboxazid—Agitation—Imiquimod—skin cancer	0.00885	0.0125	CcSEcCtD
Isocarboxazid—Syncope—Imiquimod—skin cancer	0.00864	0.0122	CcSEcCtD
Isocarboxazid—MAOA—connective tissue—skin cancer	0.0086	0.0571	CbGeAlD
Isocarboxazid—Palpitations—Imiquimod—skin cancer	0.00851	0.012	CcSEcCtD
Isocarboxazid—Loss of consciousness—Imiquimod—skin cancer	0.00847	0.012	CcSEcCtD
Isocarboxazid—Ataxia—Fluorouracil—skin cancer	0.0083	0.0118	CcSEcCtD
Isocarboxazid—MAOB—mammalian vulva—skin cancer	0.0083	0.0551	CbGeAlD
Isocarboxazid—Dry mouth—Imiquimod—skin cancer	0.00802	0.0113	CcSEcCtD
Isocarboxazid—Constipation—Vemurafenib—skin cancer	0.00788	0.0112	CcSEcCtD
Isocarboxazid—Dysuria—Temozolomide—skin cancer	0.00775	0.011	CcSEcCtD
Isocarboxazid—Shock—Imiquimod—skin cancer	0.00773	0.0109	CcSEcCtD
Isocarboxazid—Pollakiuria—Temozolomide—skin cancer	0.00765	0.0108	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Temozolomide—skin cancer	0.00763	0.0108	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Imiquimod—skin cancer	0.0076	0.0108	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Temozolomide—skin cancer	0.00756	0.0107	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Temozolomide—skin cancer	0.00724	0.0102	CcSEcCtD
Isocarboxazid—MAOB—female reproductive system—skin cancer	0.00711	0.0472	CbGeAlD
Isocarboxazid—MAOA—mammalian vulva—skin cancer	0.00708	0.047	CbGeAlD
Isocarboxazid—Paraesthesia—Imiquimod—skin cancer	0.00706	0.00999	CcSEcCtD
Isocarboxazid—Chills—Bleomycin—skin cancer	0.00705	0.00998	CcSEcCtD
Isocarboxazid—Somnolence—Imiquimod—skin cancer	0.00699	0.00989	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Fluorouracil—skin cancer	0.00697	0.00986	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Fluorouracil—skin cancer	0.00667	0.00944	CcSEcCtD
Isocarboxazid—Hallucination—Temozolomide—skin cancer	0.0066	0.00934	CcSEcCtD
Isocarboxazid—Chills—Dactinomycin—skin cancer	0.00658	0.00931	CcSEcCtD
Isocarboxazid—Lethargy—Docetaxel—skin cancer	0.0065	0.0092	CcSEcCtD
Isocarboxazid—Diarrhoea—Vemurafenib—skin cancer	0.00631	0.00893	CcSEcCtD
Isocarboxazid—Dizziness—Vemurafenib—skin cancer	0.0061	0.00863	CcSEcCtD
Isocarboxazid—MAOA—female reproductive system—skin cancer	0.00606	0.0402	CbGeAlD
Isocarboxazid—Ataxia—Docetaxel—skin cancer	0.00599	0.00848	CcSEcCtD
Isocarboxazid—Chills—Temozolomide—skin cancer	0.00595	0.00842	CcSEcCtD
Isocarboxazid—MAOB—head—skin cancer	0.00594	0.0394	CbGeAlD
Isocarboxazid—Orthostatic hypotension—Docetaxel—skin cancer	0.00582	0.00824	CcSEcCtD
Isocarboxazid—Headache—Vemurafenib—skin cancer	0.00577	0.00817	CcSEcCtD
Isocarboxazid—Nausea—Vemurafenib—skin cancer	0.00548	0.00775	CcSEcCtD
Isocarboxazid—Tremor—Temozolomide—skin cancer	0.00541	0.00765	CcSEcCtD
Isocarboxazid—Diarrhoea—Imiquimod—skin cancer	0.00538	0.00761	CcSEcCtD
Isocarboxazid—Agitation—Temozolomide—skin cancer	0.0053	0.00751	CcSEcCtD
Isocarboxazid—Dizziness—Imiquimod—skin cancer	0.0052	0.00736	CcSEcCtD
Isocarboxazid—Palpitations—Temozolomide—skin cancer	0.0051	0.00722	CcSEcCtD
Isocarboxazid—MAOA—head—skin cancer	0.00507	0.0336	CbGeAlD
Isocarboxazid—Paraesthesia—Bleomycin—skin cancer	0.00502	0.0071	CcSEcCtD
Isocarboxazid—Headache—Imiquimod—skin cancer	0.00493	0.00697	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Docetaxel—skin cancer	0.00482	0.00681	CcSEcCtD
Isocarboxazid—Dry mouth—Temozolomide—skin cancer	0.00481	0.0068	CcSEcCtD
Isocarboxazid—Nausea—Imiquimod—skin cancer	0.00467	0.00661	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Temozolomide—skin cancer	0.00455	0.00644	CcSEcCtD
Isocarboxazid—Paraesthesia—Temozolomide—skin cancer	0.00423	0.00599	CcSEcCtD
Isocarboxazid—Somnolence—Temozolomide—skin cancer	0.00419	0.00593	CcSEcCtD
Isocarboxazid—MAOB—lymph node—skin cancer	0.00416	0.0276	CbGeAlD
Isocarboxazid—Constipation—Temozolomide—skin cancer	0.00403	0.0057	CcSEcCtD
Isocarboxazid—Chills—Docetaxel—skin cancer	0.00396	0.0056	CcSEcCtD
Isocarboxazid—Paraesthesia—Fluorouracil—skin cancer	0.0039	0.00552	CcSEcCtD
Isocarboxazid—Somnolence—Fluorouracil—skin cancer	0.00386	0.00546	CcSEcCtD
Isocarboxazid—Diarrhoea—Dactinomycin—skin cancer	0.00356	0.00504	CcSEcCtD
Isocarboxazid—MAOA—lymph node—skin cancer	0.00355	0.0235	CbGeAlD
Isocarboxazid—Syncope—Docetaxel—skin cancer	0.00344	0.00487	CcSEcCtD
Isocarboxazid—Palpitations—Docetaxel—skin cancer	0.00339	0.0048	CcSEcCtD
Isocarboxazid—Loss of consciousness—Docetaxel—skin cancer	0.00337	0.00477	CcSEcCtD
Isocarboxazid—Nausea—Bleomycin—skin cancer	0.00332	0.00469	CcSEcCtD
Isocarboxazid—Diarrhoea—Temozolomide—skin cancer	0.00322	0.00456	CcSEcCtD
Isocarboxazid—Dry mouth—Docetaxel—skin cancer	0.0032	0.00452	CcSEcCtD
Isocarboxazid—Dizziness—Temozolomide—skin cancer	0.00312	0.00441	CcSEcCtD
Isocarboxazid—Nausea—Dactinomycin—skin cancer	0.00309	0.00438	CcSEcCtD
Isocarboxazid—Shock—Docetaxel—skin cancer	0.00308	0.00436	CcSEcCtD
Isocarboxazid—Diarrhoea—Fluorouracil—skin cancer	0.00297	0.0042	CcSEcCtD
Isocarboxazid—Headache—Temozolomide—skin cancer	0.00295	0.00418	CcSEcCtD
Isocarboxazid—Dizziness—Fluorouracil—skin cancer	0.00287	0.00406	CcSEcCtD
Isocarboxazid—Paraesthesia—Docetaxel—skin cancer	0.00281	0.00398	CcSEcCtD
Isocarboxazid—Nausea—Temozolomide—skin cancer	0.0028	0.00396	CcSEcCtD
Isocarboxazid—Somnolence—Docetaxel—skin cancer	0.00279	0.00394	CcSEcCtD
Isocarboxazid—Headache—Fluorouracil—skin cancer	0.00272	0.00385	CcSEcCtD
Isocarboxazid—Constipation—Docetaxel—skin cancer	0.00268	0.00379	CcSEcCtD
Isocarboxazid—Nausea—Fluorouracil—skin cancer	0.00258	0.00365	CcSEcCtD
Isocarboxazid—Diarrhoea—Docetaxel—skin cancer	0.00214	0.00303	CcSEcCtD
Isocarboxazid—Dizziness—Docetaxel—skin cancer	0.00207	0.00293	CcSEcCtD
Isocarboxazid—Headache—Docetaxel—skin cancer	0.00196	0.00278	CcSEcCtD
Isocarboxazid—Nausea—Docetaxel—skin cancer	0.00186	0.00263	CcSEcCtD
Isocarboxazid—MAOB—Metabolism—PLIN2—skin cancer	0.000796	0.00684	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CSPG4—skin cancer	0.000642	0.00551	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—BRAF—skin cancer	0.000612	0.00526	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PLIN2—skin cancer	0.0005	0.00429	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—BRAF—skin cancer	0.000469	0.00403	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ENO2—skin cancer	0.000436	0.00375	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CSPG4—skin cancer	0.000403	0.00346	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—IL6—skin cancer	0.000328	0.00282	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—HRAS—skin cancer	0.000281	0.00242	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ENO2—skin cancer	0.000274	0.00235	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ERCC2—skin cancer	0.000253	0.00218	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—HRAS—skin cancer	0.000215	0.00185	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ERCC2—skin cancer	0.000159	0.00137	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PTGS2—skin cancer	0.000152	0.00131	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PTGS2—skin cancer	9.53e-05	0.000819	CbGpPWpGaD
